Showing results (71-80 of 306) with videos related to
Sort By:
Pageof 31
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2025
Pharmacokinetics and pharmacodynamics of AQST-109: phase 3 results comparing epinephrine sublingual film with intramuscular injectionDavid Golden, Matthew Greenhawt, Nils Confer, et al.The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2024
Evolving Food Allergy Clinical Trials to Become More Patient-CenteredJennifer A Dantzer, Marcus S Shaker, Matthew GreenhawtAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2018
An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxisMarcus Shaker, Tsuzumi Kanaoka, Lynn Feenan, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 15, 2019
The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapyDi Sun, Joseph Cafone, Marcus Shaker, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 22, 2014
What affects quality of life among caregivers of food-allergic children?Laura Howe, Timothy Franxman, Esther Teich, et al.Current Allergy and Asthma Reports|September 13, 2017
Wheezing in Infancy: An Overview of Recent LiteratureChristine Muglia, John OppenheimerCurrent Opinion in Allergy and Clinical Immunology|November 6, 2019
Asthma/obstructive pulmonary disease overlap: update on definition, biomarkers, and therapeuticsAugust Generoso, John OppenheimerThe Journal of Allergy and Clinical Immunology. in Practice|November 1, 2020
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical PracticeMauli Desai, John OppenheimerImmunology and Allergy Clinics of North America|April 4, 2017
Patient Characteristics and Individualization of Biologic TherapySteven Draikiwicz, John OppenheimerCurrent Opinion in Allergy and Clinical Immunology|June 11, 2011
Controversies regarding long-acting β2-agonistsReena Khianey, John OppenheimerPageof 31